Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Longitudinal HRQoL in Japanese patients with advanced urothelial carcinoma receiving immune checkpoint inhibitors
jRCT1051230211Recruiting
- Start
- Dec 2017
- Countries
- 1
01
Overview
Single-arm trial in transitional cell carcinoma (TCC), sponsored by none. Primary endpoint: Health-related quality of life. Started Dec 2017; status: recruiting.
02
Conditions
transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on jRCT1051230211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051230211.